Medirom Decides to Double Installation of Authentication Device "Orb" to 200 Stores, in Collaboration with "World" Co-founded by Sam Altman and Alex Blania
MWN-AI** Summary
Medirom Healthcare Technologies Inc. (NASDAQ: MRM), headquartered in Tokyo, has announced a significant collaboration with "World," a global project co-founded by tech leaders Sam Altman and Alex Blania, aimed at developing a "proof of human" authentication protocol. As part of this initiative, Medirom plans to double the installation of its "Orb" authentication devices to 200 locations across Japan, specifically within its Re.Ra.Ku relaxation studios.
This deployment, set to be completed by the end of September 2025, represents the most extensive installation of Orbs in Japan to date, enhancing the ability of users to prove their identity in an era increasingly defined by the rise of generative AI and concerns about distinguishing humans from machines. The Orb, an advanced technology, verifies an individual's humanness automatically without revealing their identity, thereby facilitating the issuance of a secure, verified World ID.
By embracing World ID, Medirom underscores its commitment to integrating healthcare and technology to improve user experience in Japan’s wellness sector. The introduction of the Orb is seen as a progressive step in creating a robust framework for digital identity verification, enabling seamless access across various services.
Medirom operates over 300 relaxation studios nationwide and has expanded its portfolio in health technology since 2015, venturing into developments such as the MOTHER Bracelet, a battery-free smart tracker. This latest collaboration with World demonstrates Medirom's forward-thinking approach in anticipating market trends and fostering a trustworthy digital ecosystem.
As it advances, Medirom remains focused on its growth strategies while navigating potential economic and operational uncertainties that may impact its business objectives.
MWN-AI** Analysis
Medirom Healthcare Technologies Inc. (NASDAQ: MRM) has made a significant strategic move by deciding to double its installation of the Orb, an authentication device developed in collaboration with World, co-founded by notable figures Sam Altman and Alex Blania. By expanding from 100 to 200 Re.Ra.Ku relaxation studios across Japan, Medirom positions itself at the forefront of the rapidly evolving intersection of healthcare and technology.
This initiative highlights the increasing importance of digitization and user verification in the healthcare sector, especially as trust becomes paramount in a world increasingly populated by generative AI. The deployment of the Orb aims to enhance user experience, allowing customers to prove their “humanness” without compromising privacy. This move could also bolster Medirom's competitive position within the wellness and health tech markets.
For investors, this initiative represents a dual opportunity: first, as a lever to increase foot traffic in Medirom’s existing locations, attracting new customers who value data privacy, and second, as a potential revenue driver through expanded services that integrate World ID technology. Given the growing consumer preference for secure digital interactions, Medirom's commitment to integrating such technology could yield a strong leverage in customer retention and loyalty.
However, market participants should remain cognizant of potential risks. The successful implementation of this technology will require strategic execution and consumer adoption. Additionally, inherent uncertainties related to regulatory environments and operational execution warrant close monitoring.
In conclusion, investors should take a bullish stance on Medirom's long-term strategy but exercise caution in the short term. The expansion aligns well with current market trends favoring digital security solutions, thus offering potential for capital appreciation.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
TOKYO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM), a diversified healthcare company, has joined “World,” a “proof of human” protocol co-founded by Sam Altman and Tools for Humanity’s CEO, Alex Blania. MEDIROM plans to complete the deployment of the World ID proof of human authentication device Orb across 100 of its Re.Ra.Ku relaxation studios in Japan within this month, and to expand the deployment to 200 locations nationwide further. This expansion marks the largest installation of Orbs in Japan to date, providing greater access to this new social infrastructure that enables individuals to prove their unique humanness.
Through the integration of healthcare and technology, MEDIROM is committed to driving the adoption of World ID in Japan.
?About World ID
World ID is a global authentication technology that proves “humanness.”
In recent years, with the rapid evolution of generative AI, we are entering a society where it is difficult to distinguish between humans and AI. Against this backdrop, World ID aims to provide “digital proof of human”.
The Orb, an advanced camera, is used to verify humanness of individuals without identifying them.
Once verification is complete, a verified World ID is issued and stored in World App, enabling its use across various compatible services.
? ?About Re.Ra.Ku Group
Re.Ra.Ku Group operates more than 300 relaxation studios nationwide, centered around Re.Ra.Ku. In addition to “Re.Ra.Ku,” which is located in commercial facilities and street-front stores, the group also operates five other brands: “Spa Re.Ra.Ku,” which is located in hot spring facilities; “Re.Ra.Ku PRO,” which operates a multi-purpose running station; “Bell Epoc,” which offers a wide range of services such as reflexology and aromatherapy body care, mainly in rural areas; and “Ruam Ruam,” which offers Asian massage techniques.
Web https://reraku.jp/
? ?About MEDIROM Group
MEDIROM Group operates over 300 wellness salons under the "Re.Ra.Ku®" brand nationwide. Since 2015, we have expanded into HealthTech, offering on-demand training apps like Lav® for specific health guidance and lifestyle improvement programs. In 2020, we started manufacturing the battery-free smart tracker "MOTHER Bracelet®," which is now used in REMONY, our remote monitoring system for various industries including caregiving, transportation, construction, and manufacturing.
About MEDIROM Healthcare Technologies Inc.
NASDAQ Symbol: MRM
Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan
Web https://medirom.co.jp/en
*The plans, forecasts, and figures included in this release are as of September 25, 2025, and may be subject to change without notice.
*World, WorldID, Worldcoin, and Orb are trademarks or registered trademarks of Tools for Humanity Corporation.
*MOTHER Bracelet® is a registered trademark of MEDIROM Healthcare Technologies Inc.
Contact
Medirom Healthcare Technologies Inc. — Email: press@medirom.co.jp
Forward-Looking Statements Regarding MEDIROM
Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include:
? MEDIROM’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives;
? changes in Japanese and global economic conditions and financial markets, including their effects on MEDIROM’s expansion in Japan and certain overseas markets;
? MEDIROM’s ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment;
? the fluctuation of foreign exchange rates, which affects MEDIROM’s expenses and liabilities payable in foreign currencies;
? MEDIROM’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property;
? MEDIROM’s ability to raise additional capital on acceptable terms or at all;
? MEDIROM’s level of indebtedness and potential restrictions on MEDIROM under MEDIROM’s debt instruments;
? changes in consumer preferences and MEDIROM’s competitive environment;
? MEDIROM’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and
? the regulatory environment in which MEDIROM operates.
More information on these risks and other potential factors that could affect MEDIROM’s business, reputation, results of operations, financial condition, and stock price is included in MEDIROM’s filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of MEDIROM’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/babdf997-be0c-4690-9e48-292e4dcd8353
https://www.globenewswire.com/NewsRoom/AttachmentNg/6270b959-b29d-4a3c-9458-a01af74585c7
https://www.globenewswire.com/NewsRoom/AttachmentNg/2efbc868-5d87-4be2-a59c-7da49c2351c7
https://www.globenewswire.com/NewsRoom/AttachmentNg/56d20655-dea0-4b30-adbb-a69e2bb4e5dc
FAQ**
How does MEDIROM Healthcare Technologies Inc. MRM plan to differentiate itself in the growing health tech sector with its deployment of World ID authentication devices in Japan?
What potential risks does MEDIROM Healthcare Technologies Inc. MRM foresee in its expansion strategy with the new World ID and how will it mitigate them?
In what ways does the integration of the World ID technology influence MEDIROM Healthcare Technologies Inc. MRM's overall business model and future growth?
What are the expected financial implications for MEDIROM Healthcare Technologies Inc. MRM resulting from the deployment of the Orb devices across its relaxation studios in Japan?
**MWN-AI FAQ is based on asking OpenAI questions about MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM).
NASDAQ: MRM
MRM Trading
-2.38% G/L:
$1.23 Last:
9,966 Volume:
$1.23 Open:
